📣 Introducing Tracenable Pro: Unlock Unlimited Data Exports & Disclosures Access.
Alliance Pharma Ltd
Alliance Pharma's GHG Emissions Data Preview
In 2024, Alliance Pharma completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
Alliance Pharma has also provided a category-level breakdown for 10 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 2 | ||||
Market-Based | Copy restricted. Please purchase to unlock this data. a | Copy restricted. Please purchase to unlock this data. a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Location-Based | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data. a | Copy restricted. Please purchase to unlock this data. a | Copy restricted. Please purchase to unlock this data.  | 0000000 |
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
aVerified Sources Behind Alliance Pharma’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Alliance Pharma’s data sources below and access millions more through our Disclosure Search.
Insights into Alliance Pharma's Operational Emissions
In 2024, the total operational greenhouse gas (GHG) emissions ofAlliance Pharma amounted to45.5metric tons of CO2 equivalent.This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2023, the total operational greenhouse gas (GHG) emissions of Alliance Pharmadecreased by 0.18%, showing that the company has made progress in taking action to reduce the climate impact of its operations.a
Alliance Pharma's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Alliance Pharma's Scope 1 emissions?
In 2024, the total Scope 1 emissions of Alliance Pharma were 0 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).a
Has Alliance Pharma reduced its Scope 1 emissions over time?
Since 2022, Alliance Pharma's Scope 1 emissions have decreased by 100%, reflecting a declining long-term trend in Scope 1 emissions over time.a
What are Alliance Pharma's Scope 2 emissions?
In 2024, Alliance Pharma reported Scope 2 greenhouse gas (GHG) emissions of 0 tCOâ‚‚e using the market-based method and 45.5 tCOâ‚‚e using the location-based method.a
Has Alliance Pharma reduced its Scope 2 emissions over time?
Since 2022, Alliance Pharma's Scope 2 greenhouse gas (GHG) emissions (Location-Based)have remained relatively stable, indicating that Alliance Pharma's emissions have plateaued with no significant change in its energy consumption footprint.a
Compared to the previous year(2023), Alliance Pharma's Scope 2 emissions(Location-Based) have remained relatively stable, indicating that Alliance Pharma's emissions have plateaued with no significant change in its energy consumption footprint.a
What methodology does Alliance Pharma use for Scope 2 reporting?
In 2024, Alliance Pharma reported its Scope 2 emissions using the market-based method and using the location-based method.a
Alliance Pharma's Scope 2 Emissions Over Time
- Total Scope 2 Location-Based
- Total Scope 2 Market-Based
Insights into Alliance Pharma's Value Chain Emissions
In 2024, Alliance Pharma reported 38,957 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a
The 2024 disclosure of Alliance Pharma includes a breakdown across 10of the 15 Scope 3 categories defined by the GHG Protocol,matching the level of disclosure in 2023, demonstrating consistent Scope 3 emissions reporting coverage year over year.a
Alliance Pharma's Scope 3 Emissions Over Time
- Total Scope 3
- Year-over-Year Change
What are Alliance Pharma's Scope 3 emissions?
In 2024, Alliance Pharma reported total Scope 3 emissions of 38,957 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).a
Approximately 99.59%of these emissions originated from upstream activities such as purchased goods and capital goods, while 0.41%came from downstream activities like product use, distribution, and end-of-life treatment.a
Has Alliance Pharma reduced its Scope 3 emissions over time?
Since 2022, Alliance Pharma's Scope 3 emissionshave decreased by 14.57%, reflecting a declining long-term trend in Scope 3 emissions over time.a
Compared to the previous year (2023), Alliance Pharma's Scope 3 emissions decreased by 22.07%, highlighting the company's efforts to lower indirect emissions from its value chain.a
What categories of Scope 3 emissions does Alliance Pharma disclose?
In 2024, Alliance Pharma reported emissions for 10 out of the 15 Scope 3 categories defined by the GHG Protocol.a
This reflects a high level of granularity and transparency in the company's emissions reporting.
What are the main sources of Alliance Pharma's Scope 3 emissions?
In 2024, the largest contributors to Alliance Pharma's Scope 3 emissions were:a
- Purchased Goods and Services (Cat. 1): 33,418 tCOâ‚‚e(85.78%)
- Upstream Transportation and Distribution (Cat. 4): 2,877 tCOâ‚‚e(7.39%)
- Downstream Transportation and Distribution (Cat. 9): 1,114 tCOâ‚‚e(2.86%)
Alliance Pharma's Scope 3 Emissions by Categories
Insights into Alliance Pharma's Total Carbon Footprint
In 2024, Alliance Pharma reported a total carbon footprint of 39,002.5 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 22.05% decrease compared to 2023, indicating progress in reducing its overall greenhouse gas output.a
The largest contributor to Alliance Pharma's total carbon footprint was Scope 3 emissions, accounting for 99.88% of the company's total carbon footprint, followed by Scope 2 emissions at 0.12%.a